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Genetic improvement in growth rate and feed 
efficiency has allowed modern broilers to reach 
market weight in a shorter period of time. However, 
selection for these economically important traits 
has been accompanied by an increase in the number 
of problems encountered during production, in-
cluding obesity, ascites, sudden death syndrome 
and leg abnormalities (Siegel and Dunnington, 
1985; Mench, 2002; Tolkamp et al., 2005). Broiler 
chicks are prone to be overfatty, resulting from 
hyperpyagia when provided free access to feed. 
Although feed restriction could decrease the fat 
deposition in broilers (Jones and Farrell, 1992; 
Nielsen et al., 2003), it is accompanied by a de-
crease in growth rate.
Birds have the ability to store large quantities 
of excessive fat in liver, adipose tissue (Hermier, 
1997). Lipogenesis (i.e. the conversion of glucose 
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sensitive triglyceride lipase activity in liver and abdominal fat (P < 0.05). The lipoprotein lipase activity in 
abdominal fat was significantly decreased by dihydropyridine (P < 0.05). The activity of glucose-6-phosphate 
dehydrogenase and malic dehydrogenase in liver was significantly reduced, whereas the isocitrate dehydro-
genase activity in liver was not affected by dietary dihydropyridine. The content of cAMP was significantly 
increased by dihydropyridine, but malondialdehyde content was decreased (P < 0.05). Dihydropyridine at 
doses of 100 and 200 mg/kg increased apolipoprotein B (P < 0.05), but 300 mg/kg dihydropyridine had no 
effect on apolipoprotein B compared with the control group. Triiodothyronine was significantly increased 
by dietary dihydropyridine (P < 0.05). There were no differences in apolipoprotein A, cholesterol, trigly-
cerides, high density lipoprotein-cholesterol, very low density lipoprotein-cholesterol, thyroxine and insulin 
among dietary treatments. It is concluded that supplementing dihydropyridine has a beneficial effect on 
feed efficiency and lipid metabolism of broilers, and that 200 mg/kg dihydropyridine supplementation is 
the optimum dose. 
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to triglycerides) takes place primarily in the liver 
of birds and involves in a series of linked, enzyme- 
catalyzed reactions including glycolysis, the citric 
acid cycle and fatty acid synthesis. Hepatic lipogen-
esis is subjected to both the nutritional and hor-
monal control and this metabolic process is highly 
responsive to changes in the diet (Hillgartner et al., 
1995; Kersten, 2001). The nutritional state of the 
bird, as determined by the amount and composition 
of feed consumed, dramatically affects the hepatic 
lipid metabolism (Hillgartner et al., 1995).
Dihydropyridine is a new multifunctional antioxi-
dant in food (Kouřimská et al., 1993; Smagin, 1998; 
Tirzitis and Kirule, 1999; Pánek et al., 2000; Tirzitis 
et al., 2001). It has been shown that dihydropyridine 
has the antioxidant and immunological activity in 
ducks (Bakutis and Bukis, 1984) and chickens (Vald- 
man et al., 1990). Dihydropyridine improved the 
health of cows, improved the quality of milk, and 
increased cow fertility (Sutkevicius et al., 1984). It 
also reduced the body weight loss in young fattened 
cattle during transport to the meat-packing plant 
(Spruzh and Igaune, 1991). Dihydropyridine also 
regulated the lipid metabolism in humans (Zhang 
et al., 2002). The study indicated that dihydropy-
ridine could improve the laying performance and 
decrease hepatic fat and abdominal fat in laying 
hens (Zou et al., 2007). Furthermore, dihydropy-
ridine, as a calcium channel blocker or calcium 
antagonist, is the effective drug in curing cardi-
ovascular diseases in humans, including angina, 
hypertension, myocardial ischemia, cardiac failure 
and atherosclerosis (Luft and Haller, 1993; Zhang, 
1996). However, there is no report on the regulation 
of lipid metabolism by dihydropyridine in broiler 
chickens. The objective of this study is to evaluate 
the effects of dietary dihydropyridine supplementa-
tion on growth performance and lipid metabolism 
of broilers to provide the clue for developing a new 
kind of feed additive which could effectively reduce 
the fat deposition in broilers.
MATERIAL AND METHODS
Experimental design and birds
This experiment was conducted according to 
protocols approved by the Northwest A and F 
University Animal Care and Use Committee. A to-
tal of 480 one-day-old female Arbor Acres broiler 
chicks were obtained from a local hatchery and 
randomly divided into four groups, each group had 
six replications, and each replication 20 birds. The 
birds were fed maize-soybean meal basal diet sup-
plemented with 0, 100, 200, or 300 mg/kg dihy-
dropyridine, respectively. The dihydropyridine was 
provided by Sunpu Biochem. Tech. Co., Ltd, Beijing, 
China. Feed and water were provided ad libitum. 
The photoperiod was set at 22L:2D throughout the 
whole experimental period. The room temperature 
was at 35°C at the first day and gradually reduced 
to 25°C by the end of the third week.
At the end of the experiment, two birds from 
each replication were killed after 12 h fasting and 
ad libitum access to water. Abdominal fat pad and 
liver weight were determined.
Blood samples were obtained via the vena cava 
puncture. The serum was transferred into an 
Eppendorf centrifuge tube (10 ml), centrifuged for 
10 min, and then kept at –30°C for analysis. 
Experimental parameters measured
Hepatic fat percentage: Liver samples were ho-
mogenized and dried to constant weight at 105°C. A 
dried sample (2 g) was extracted with a chloroform:
ether mixture (5:1) in a Soxhlet apparatus for 8 h, 
and the extracted sample was dried to constant 
weight at 105°C. Fat weight was calculated by sub-
tracting the sample weight after extraction from 
the sample weight before extraction and hepatic 
fat percentage as: fat weight/dried liver weight × 
100%.
SOD activity, apoA, apoB and MDA content in 
liver: The liver tissue was homogenized with 0.9% 
sodium chloride solution to make a 10% hepatic 
mixture, which was then centrifugated at 2 000 g 
for 10–15 min, the upper pellucid liquid was taken 
for parameter determination. The SOD activity was 
determined by colorimetry according to the assay 
kit provided by Nanjing Jiancheng Bioengineering 
Institute. ApoA, apoB and MDA contents were 
determined with a UV-2000 spectrophotometer 
(UNICO Instruments Co., Ltd., Shanghai, China) 
using analysis kits provided by Ningbo City Bio-
chemical Reagent Factory and Nanjing Jiancheng 
Bioengineering Institute, China.
Biochemical parameters related to fat metabo-
lism: Serum triglycerides (TG), cholesterol, high 
density lipoprotein-cholesterol (HDL-C), and very 
low density lipoprotein-cholesterol (VLDL-C) were 
measured with an ERBA CHEM-5 semi-automatic 118
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biochemical analyzer using analysis kits provided 
by Ningbo City Bio-chemical Reagent Factory, 
China. 
HSL activity was measured using the method 
reported by Shih et al. (1995). The fat was minced 
and homogenized in 10 volumes of pH 7.0 medium 
containing 0.25M sucrose, 1mM EDTA, 4 μg/ml 
leupeptin, 1 μg/ml pepstatin A, and 1mM dithio-
threitol, then centrifuged at 105 000 g for 45 min 
at 4°C. The superficial fat cake was removed and 
the clear supernatant decanted and used for the 
assay of HSL activity based on the standard assay 
procedure of Nilsson-Ehle and Schotz. The assay 
substrate was prepared immediately before use to 
give a final concentration of each reagent in the 
200 μl assay volume as follows: 100 mmol/l Tris 
HCl, pH 7.0; 5 g/l of BSA (fatty acid-free, fraction 
V), and 4.58 mmol/l triolein as substrate. A unit 
of HSL activity was defined as: one HSL activity 
unit is the concentration of enzyme that hydrolyzes 
1 µmol olive oil in one minute at 37°C.
The activity of glucose-6-phosphate dehydro-
genase (G-6-PDH), malic dehydrogenase (MDH), 
isocitrate dehydrogenase (ICD) in liver, and lipo-
protein lipase (LPL) in abdominal fat were deter-
mined as reported before (Xu et al., 2003).
Hormone concentrations: Concentrations of 
triiodothyronine (T3), thyroxine (T4) and insulin 
in serum were measured using an RIA kit (Beijing 
North Immunological Institute, China) and a gam-
ma-counter (Packard 8500, USA).
Statistical analysis: All the data were analyzed 
statistically using the general linear model proce-
dure (SAS Institute, 1989) and the treatment means 
were separated by Duncan’s multiple range test   
(P = 0.05).
RESULTS
Body weight at 42 days, feed intake, feed/gain, 
abdominal fat and liver fat are shown in Table 2. 
Table 1. Ingredients and nutrient level of basal diets
Ingredients (g/kg) 1–21 days 22–42 days
Maize 610.0 640.0
Soybean meal 290.0 270.0
Rapeseed meal 30.0 40.0
Fish meal 20.0 –
Soy oil 10.0 10.0
Monocalcium phosphate 15.0 15.0
Limestone 12.0 12.0
Salt 3.0 3.0
Premix1 10.0 10.0
Nutrition level2
ME (MJ/kg) 12.46 12.65
CP (g/kg) 215.8 197.5
Ca (%) 1.0 1.0
Available phosphorus (%) 0.41 0.40
Lys (g/kg) 11.6 10.7
Met + Cys (g/kg) 9.3 7.9
1provided per kilogram of diet: vitamin A 1 600 IU; vitamin E 10 mg; vitamin D3 220 IU; niacin 35.0 mg; d-pantothenic 
acid 12 mg; riboflavin 3.6 mg; pyridoxine 3.5 mg; thiamine 2.4 mg; menadione 1.3 mg; folic acid 1.4 mg; biotin 0.15 mg; 
vitamin B12 0.03 mg; Mn 60 mg; Zn 40 mg; Fe 80 mg; Cu 8 mg; I 0.3 mg; Se 0.2 mg
2ME value is calculated, the other nutrition levels are analysized119
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Compared with the control group, there were sig-
nificant differences (P < 0.05) in feed efficiency, 
abdominal fat percentage and liver fat percentage 
by supplementing dihydropyridine. Supplements of 
100, 200 or 300 mg/kg dihydropyridine improved 
feed efficiency by 8.4%, 15.0%, and 12.0%, decreased 
liver fat by 23.6%, 26.7%, and 26.0%, and decreased 
abdominal fat by 24.5%, 25.9%, and 23.3% (P < 0.05) 
respectively. There were no significant differences 
in feed efficiency, abdominal fat percentage and 
liver fat percentage among 100, 200, and 300 mg/kg 
dietary dihydropyridine (P < 0.05). No significant 
differences were observed in body weight and feed 
intake (P > 0.05).
The activities of enzymes related to lipid me-
tabolism are shown in Table 3. 100 mg/kg dihy-
dropyridine had no effect on HSL activity in liver 
or abdominal fat, while a higher level of dietary di-
hydropyridine supplementation (200 or 300 mg/kg) 
increased the HSL activity (P < 0.05). The LPL ac-
tivity in abdominal fat was significantly decreased 
by dihydropyridine (P < 0.05). The activity of   
G-6-PDH and MDH in liver was significantly de-
creased, whereas the ICD activity in liver was not 
significantly affected by dietary dihydropyridine.
There were significant effects of dietary dihy-
dropyridine on cAMP, SOD, and MDA (P < 0.05, 
Table 3), content of cAMP was increased (P < 0.05), 
Table 2. Effects of dihydropyridine on growth performance
Item
Dihydropyridine (mg/kg)
SEM
0 100 200 300
Body weight (g/bird) 2 123 2 133 2 198 2 138 24.80
Feed intake (g/bird) 4 085 3 768 3 687 3 633 3.65
Feed/gain 1.92a 1.76b 1.67b 1.69b 0.05
Liver fat (% in dry weight) 31.52a 24.14b 23.10b 23.01b 2.60
Abdominal fat (% BW) 4.21a 3.18b 3.12b 3.23b 0.32
a,bmeans with different superscripts in the same row are significantly different (P < 0.05)
Table 3. Effects of dihydropyridine on the activity of enzymes related to lipid metabolism and contents of cAMP 
and MDA1
Item
Dihydropyridine (mg/kg)
SEM
0 100 200 300
HSL in liver (IU) 28.16a 29.82a,b 38.12b 36.26b 0.49
HSL in abdominal fat (IU)  15.21a 17.34a,b 22.25b 21.67b 0.70
LPL in abdominal fat (IU) 11.52a 9.12b 8.89b 9.34b 0.13
ICD in liver (IU) 19.83 17.45 17.67 17.87 1.23
MDH in liver (IU) 9.62a 7.23b 6.89b 7.32b 0.32
G-6-PDH in liver (IU) 6.51a 5.15b 4.98b 4.45b 0.13
cAMP (pm/g) 245.16a 282.45b 291.23b 289.34b 12.25
SOD (U/mg) 22.01a 32.65b 37.12b 34.75b 2.34
MDA (nmol/l) 1.43a 1.13b 1.01b 1.06b 0.15
a,bmeans with different superscripts in the same row are significantly different (P < 0.05)
1HSL = hormone-sensitive triglyceride lipase; LPL = lipoprotein lipase; ICD = isocitrate dehydrogenase; MDH = malic 
dehydrogenase; G-6-PDH = glucose-6-phosphate dehydrogenase; SOD = superoxide dismutase; MDA = malondialdehyde120
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SOD activity was increased (P < 0.05), and MDA 
content was decreased (P < 0.05) 100 and 200 mg 
per kg dihydropyridine increased ApoB (P < 0.05, 
Table 4), but 300 mg/kg dihydropyridine had no 
effect on ApoB compared with the control group. 
T3 was significantly increased by dietary dihydro-
pyridine (P < 0.05). There were no differences in 
ApoA, cholesterol, TG, HDL-C, VLDL-C, T4, and 
insulin among dietary treatments. 
DISCUSSION
The results of this study demonstrated that sup-
plements of dihydropyridine could significantly 
improve feed efficiency and reduce fat deposition 
in broiler chickens. This is similar to the results 
reported by Chen et al. (1993) and Zou et al. (1999, 
2007) in laying hens.
Lipogenic and lipolytic enzymes in liver and ab-
dominal fat were determined to investigate the ef-
fect of dihydropyridine on lipid metabolism. MDH, 
ICD and G-6-PDH are responsible for generating 
NADPH for the support of lipogenesis while hor-
mone-sensitive lipase has the opposite effect of mo-
bilizing fatty acids from adipocytes into the blood 
stream in the process of lipolysis. Lipoprotein lipase 
in adipose tissue is involved in the movement of fat-
ty acids from TG in blood chylomicrons and VLDL 
to the adipocytes (Gondret and Lebret, 2002; Xu et 
al., 2003; Kokta and Dodson, 2004; Pashkov et al., 
2005). At 42 days of age, the activities of NADPH-
generating enzymes were significantly decreased 
in liver and abdominal fat by dietary dihydropyri-
dine, whereas HSL was significantly increased. It is 
evident that changes in the deposition of liver and 
abdominal fat are closely associated with patterns 
of HSL and NADPH-generating enzymes. The en-
zymatic machinery of liver and adipose tissue has 
adapted in such a way as to increase or decrease 
the capacity for NADPH generating for fatty acid 
synthesis and mobilization of fatty acids from adi-
pose tissue, thereby facilitating the use of energy 
toward the maintenance and growth process (Diaz 
et al., 1999; Lien and Jan, 1999). 
The present study demonstrated that dihydro-
pyridine significantly increased the SOD activity 
of serum and liver in broilers and significantly de-
creased MDA content in liver. This observation is 
similar to the results of Sniedze et al. (1977), who 
showed that dihydropyridine had an antioxidant 
function in animals and reduced the oxidation of 
lipid compounds. SOD protects important organs 
from the attack by free radicals and maintains their 
normal physiological function by disposing of ex-
cessive free radicals. Paradis et al. (1997) reported 
that dihydropyridine combined with terminal oxi-
dase cytochrome p450 to form a complex which 
Table 4. Effects of dihydropyridine on apolipoprotein content in liver, and serum biochemical parameters1
Item
Dihydropyridine (mg/kg)
SEM
0 100 200 300
ApoB (mg/100 mg protein) 32.15a 41.62b 44.75b 38.23b 3.02
ApoA (mg/100 mg protein) 21.12 21.25 23.05 20.88 1.20
Cholesterol (mg/dl) 114.58 111.24 114.15 116.35 23.34
TG (mmol/l) 12.21 11.58 10.15 12.67 2.68
VLDL-C (mmol/l) 1.45 1.31 1.15 1.27 0.78
HDL-C (mg/dl) 120.32 126.18 135.72 124.96 19.87
T3 (ng/ml) 1.92a 2.25b 2.33b 2.30b 0.12
T4 (ng/ml) 20.16 21.22 20.83 21.11 2.98
Insulin (ng/ml) 0.28 0.31 0.33 0.31 0.05
a,bmeans with different superscripts in the same row are significantly different (P < 0.05)
1ApoA = apolipoprotein A; ApoB = apolipoprotein B; TG = triglycerides; VLDL-C = very low density lipoprotein-cholesterol; 
HDL-C = high density lipoprotein-cholesterol; T3 = triiodothyronine; T4 = thyroxine121
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significantly restrained the activity of NADPH-cy-
tochrome reductase, restrained NADPH produc-
tion and then reduced lipid superoxidation. 
Results of this study also showed that dihydropy-
ridine significantly improved the level of apolipo-
protein B in liver. ApoB 100 is a major component 
of VLDL, which transports triglycerides out of liver. 
Yin et al. (2000) showed by immune electron mi-
croscopy that fat was joined to the apoB chain to 
form VLDL, which then transports endogenous fat 
to extrahepatic tissues. 
The present results demonstrated that dihy-
dropyridine increased the T3 level in serum and 
simultaneously decreased the insulin level, which 
agrees with observations of Wu et al. (1999) in 
pigs. T3 plays an important role in regulating 
the protein and lipid metabolism. An increase in 
T3 concentration could increase fat mobilization 
and hydrolysis, and insulin has the reverse ef-
fects. Valcavi et al. (1997) and Tashi et al. (1998) 
found that there was a positive correlation be-
tween thyroxine and leptin levels and that thyrox-
ine stimulated the secretion of leptin. Leptin is a 
protein secreted by adipocytes which maintains 
the relative stability of body fat by regulating the 
energy metabolism. Leptin absence will induce 
an increased insulin level in serum and stimulate 
hepatic fatty acid synthesis, as already shown in 
mice with leptin absence. In mice whose leptin 
receptor genes were knocked-out, symptoms of 
insulin resistance and fatty liver were still present 
even if the serum leptin level increased. So it is 
speculated that dihydropyridine can regulate the 
fat metabolism of laying hens through regulating 
the secretion of leptin in adipocytes. 
In conclusion, the present research indicated 
that dietary dihydropyridine could improve feed 
efficiency and decrease hepatic fat percentage and 
abdominal fat percentage by affecting the fat me-
tabolism in broilers. 200 mg/kg dihydropyridine is 
the optimum dose. 
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